On January 31, 2024, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock payable on March 4, 2024 to shareholders of record on February 12, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.25 USD | -0.16% | -0.65% | +3.34% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.34% | 856M | |
+12.13% | 17.56B | |
0.00% | 8.26B | |
-21.83% | 2.6B | |
-19.13% | 2.52B | |
-21.03% | 1.94B | |
-8.24% | 1.05B | |
-13.19% | 1.05B | |
-6.02% | 707M | |
-25.12% | 700M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories Inc. Approves Cash Dividend, Payable on March 4, 2024